US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor
Patent 7566450 was granted and assigned to Millennium Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.
Something went wrong.
Try refreshing the page.
Find more entities like US Patent 7566450 Humanized anti-CCR2 antibodies and methods of use therefor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.